{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:28:48Z","timestamp":1787048928922,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41390-025-04147-1","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T02:54:55Z","timestamp":1750128895000},"page":"2564-2572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vigabatrin-associated brain abnormalities on MRI (VABAM) in children with epileptic spasms"],"prefix":"10.1038","volume":"99","author":[{"given":"Ali","family":"Mir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzia","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"AlOtaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrazaq","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alhudaithy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raidah","family":"AlBaradie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Maki","family":"Shamlooh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rotenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Alhazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"4147_CR1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1471-4159.1977.tb10721.x","volume":"29","author":"MJ Jung","year":"1977","unstructured":"Jung, M. J., Lippert, B., Metcalf, B. W., B\u00f6hlen, P. & Schechter, P. J. gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J. Neurochem. 29, 797\u2013802 (1977).","journal-title":"J. Neurochem."},{"key":"4147_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1177\/1971400915598082","volume":"28","author":"V Schonstedt","year":"2015","unstructured":"Schonstedt, V., Stecher, X., Venegas, V. & Silva, C. Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms. Neuroradiol. J. 28, 515\u2013518 (2015).","journal-title":"Neuroradiol. J."},{"key":"4147_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.clinimag.2015.07.016","volume":"40","author":"K Hussain","year":"2016","unstructured":"Hussain, K., Walsh, T. J. & Chazen, J. L. Brain MRI findings with vigabatrin therapy: case report and literature review. Clin. Imaging 40, 180\u2013182 (2016).","journal-title":"Clin. Imaging"},{"key":"4147_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1528-1167.2008.01728.x","volume":"50","author":"PL Pearl","year":"2009","unstructured":"Pearl, P. L. et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia 50, 184\u2013194 (2009).","journal-title":"Epilepsia"},{"key":"4147_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1528-1167.2008.01896.x","volume":"50","author":"JW Wheless","year":"2009","unstructured":"Wheless, J. W. et al. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia 50, 195\u2013205 (2009).","journal-title":"Epilepsia"},{"key":"4147_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/jamaneurol.2013.1858","volume":"71","author":"Y Hern\u00e1ndez Vega","year":"2014","unstructured":"Hern\u00e1ndez Vega, Y., Kaliakatsos, M., U-King-Im, J. M., Lascelles, K. & Lim, M. Reversible vigabatrin-induced life-threatening encephalopathy. JAMA Neurol. 71, 108\u2013109 (2014).","journal-title":"JAMA Neurol."},{"key":"4147_CR7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/epi.13712","volume":"58","author":"SA Hussain","year":"2017","unstructured":"Hussain, S. A. et al. Risk of vigabatrin-induced brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent. Epilepsia 58, 674\u2013682 (2017).","journal-title":"Epilepsia"},{"key":"4147_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/dmcn.12188","volume":"55","author":"CY Fong","year":"2013","unstructured":"Fong, C. Y. et al. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms. Dev. Med. Child Neurol. 55, 862\u2013867 (2013).","journal-title":"Dev. Med. Child Neurol."},{"key":"4147_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer, I. E. et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58, 512\u2013521 (2017).","journal-title":"Epilepsia"},{"key":"4147_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.774828","volume":"10","author":"P Peng","year":"2022","unstructured":"Peng, P. et al. Etiologic classification of 541 infantile spasms cases: a cohort study. Front. Pediatr. 10, 774828 (2022).","journal-title":"Front. Pediatr."},{"key":"4147_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/epi.17121","volume":"63","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. Risk of vigabatrin-associated brain abnormalities on MRI: a retrospective and controlled study. Epilepsia 63, 120\u2013129 (2022).","journal-title":"Epilepsia"},{"key":"4147_CR12","doi-asserted-by":"publisher","first-page":"108606","DOI":"10.1016\/j.yebeh.2022.108606","volume":"129","author":"G Reyes Valenzuela","year":"2022","unstructured":"Reyes Valenzuela, G. et al. Vigabatrin-associated brain abnormalities on MRI and other neurological symptoms in patients with West syndrome. Epilepsy Behav. 129, 108606 (2022).","journal-title":"Epilepsy Behav."},{"key":"4147_CR13","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1080\/14737175.2020.1840356","volume":"20","author":"A Biswas","year":"2020","unstructured":"Biswas, A., Yossofzai, O., Vincent, A., Go, C. & Widjaja, E. Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis. Expert Rev. Neurother. 20, 1315\u20131324 (2020).","journal-title":"Expert Rev. Neurother."},{"key":"4147_CR14","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1111\/epi.14032","volume":"59","author":"PL Pearl","year":"2018","unstructured":"Pearl, P. L. et al. White matter spongiosis with vigabatrin therapy for infantile spasms. Epilepsia 59, e40\u2013e44 (2018).","journal-title":"Epilepsia"},{"key":"4147_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/syn.20038","volume":"53","author":"NE Preece","year":"2004","unstructured":"Preece, N. E., Houseman, J., King, M. D., Weller, R. O. & Williams, S. R. Development of vigabatrin-induced lesions in the rat brain studied by magnetic resonance imaging, histology, and immunocytochemistry. Synapse 53, 36\u201343 (2004).","journal-title":"Synapse"},{"key":"4147_CR16","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/0006-2952(87)90112-2","volume":"36","author":"RA John","year":"1987","unstructured":"John, R. A. et al. Micro-vacuolation in rat brains after long term administration of GABA-transaminase inhibitors. Comparison of effects of ethanolamine-O-sulphate and vigabatrin. Biochem Pharmacol. 36, 1467\u20131473 (1987).","journal-title":"Biochem Pharmacol."},{"key":"4147_CR17","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1111\/j.1528-1167.2010.02564.x","volume":"51","author":"A Dracopoulos","year":"2010","unstructured":"Dracopoulos, A. et al. Vigabatrin-induced reversible MRI signal changes in patients with infantile spasms. Epilepsia 51, 1528\u20131167 (2010).","journal-title":"Epilepsia"},{"key":"4147_CR18","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1111\/epi.16663","volume":"61","author":"S Bhalla","year":"2020","unstructured":"Bhalla, S. & Skjei, K. Fulminant vigabatrin toxicity during combination therapy with adrenocorticotropic hormone for infantile spasms: three cases and review of the literature. Epilepsia 61, e159\u2013e164 (2020).","journal-title":"Epilepsia"},{"key":"4147_CR19","doi-asserted-by":"publisher","unstructured":"Sathe, R. et al. Symptomatic vigabatrin-associated MRI toxicity is associated with simultaneous hormonal therapy among patients with infantile spasms. Epilepsia Open https:\/\/doi.org\/10.1002\/epi4.13099 (2024).","DOI":"10.1002\/epi4.13099"},{"key":"4147_CR20","doi-asserted-by":"publisher","unstructured":"Stevering, C. et al. Vigabatrin-associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex. Epilepsia https:\/\/doi.org\/10.1111\/epi.18190 (2024).","DOI":"10.1111\/epi.18190"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04147-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04147-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04147-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:00:48Z","timestamp":1787047248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04147-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4147"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04147-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was carried out in accordance with the code of international and local Ethics (Declaration of Helsinki). This study was reviewed and approved by the local ethics committee of the King Fahad Specialist Hospital Dammam (Dammam, Saudi Arabia).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":3,"name":"Ethics","label":"Ethical publication statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}